Markers of intestinal barrier damage in patients with chronic insomnia disorder

Markers of intestinal barrier damage in patients with chronic insomnia disorder

ObjectiveInsomnia disorder stands out as one of the prevalent clinical sleep and psychiatric disorders. Prior research has unequivocally demonstrated variations in the diversity and abundance of gut microbiota among individuals with insomnia disorder. These alterations may play a direct or indirect...

Full description

Bibliographic Details
Main Authors:	Yixian Cai, Di Gong, Ting Xiang, Xiaotao Zhang, Jiyang Pan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-03-01
Series:	Frontiers in Psychiatry
Subjects:	chronic insomnia disorder intestinal barrier diamine oxidase (DAO) D-lactic acid (D-LA) intestinal fatty acid binding protein (I-FABP) endothelin (ET)
Online Access:	https://www.frontiersin.org/articles/10.3389/fpsyt.2024.1373462/full

Similar Items

Intestinal fatty acid-binding protein, a biomarker of intestinal barrier dysfunction, increases with the progression of type 2 diabetes
by: Yifeng Wang, et al.
Published: (2021-02-01)

Liver and intestinal fatty acid-binding proteins obtain fatty acids from phospholipid membranes by different mechanisms
by: Alfred E.A. Thumser, et al.
Published: (2000-04-01)

Amelioration of intestinal barrier function and reduction of blood lead level in adult women with recurrent spontaneous abortion by a novel product of dietary fiber mixture, Holofood
by: Ye Tian, et al.
Published: (2023-07-01)

Analysis of the content of I-FABP in urine and blood serum in children with gastrointestinal food allergy
by: N. G. Prikhodchenko, et al.
Published: (2021-08-01)

Effects of delayed feeding, sodium butyrate and glutamine on intestinal permeability in newly-hatched broiler chickens
by: Saad Gilani, et al.
Published: (2018-01-01)

Intestinal fatty acid-binding protein in patients with psoriasis: A marker of impaired intestinal permeability barrier and its relation to demographic data and clinical characteristics
by: Ayman Mahran, et al.
Published: (2023-01-01)

Potential of intestinal fatty acid binding protein (I-FABP) as a biomarker in ischemia and intestinal damage
by: M. R. Kuznetsov, et al.
Published: (2024-11-01)

Standardization of a colorimetric technique for determination of enzymatic activity of diamine oxidase (DAO) and its application in patients with clinical diagnosis of histamine intolerance
by: Camila Beltrán-Ortiz, et al.
Published: (2020-09-01)

Role of diamine oxidase in the pathogenesis of chronic urticaria
by: N. V. Mikryukova, et al.
Published: (2022-03-01)

Potential of intestinal fatty acid-binding protein in assessing enteral tolerance in neonates of different gestational ages: A cross-sectional cohort study
by: I. A. Bavykina, et al.
Published: (2025-02-01)

Clinical study of intestinal mucosal function in elderly patients with moderate-to-severe AECOPD
by: Sun Tengfei, Fan Kexin, Han Junling
Published: (2022-09-01)

Capabilities of bio-binding, antioxidant and intestinal environmental repair jointly determine the ability of lactic acid bacteria to mitigate perfluorooctane sulfonate toxicity
by: Qian Chen, et al.
Published: (2022-08-01)

Cumulative effect of AOC1 gene variants on symptoms and pathological conditions in adult women with fibromyalgia: a pilot study
by: Gülşah Okutan, et al.
Published: (2023-06-01)

1-methylhistamine as a potential biomarker of food histamine intolerance. A pilot study
by: Sònia Sánchez-Pérez, et al.
Published: (2022-10-01)

A combination of plasma DAO and citrulline levels as a potential marker for acute mesenteric ischemia
by: Rıdvan Çakmaz, et al.
Published: (2013-03-01)

Peripheral Blood Levels of IL-27, IFABP, and DAO at Early Onset as Predictors of 28-Day Mortality in Enterogenic Sepsis Patients: A Single-Center, Prospective Pilot Study
by: Ni Y, et al.
Published: (2024-12-01)

Histamine intolerance (HIT)
by: Joanna Matysiak
Published: (2022-09-01)

Lactiplantibacillus plantarum fermentation enhanced the protective effect of kiwifruit on intestinal injury in rats: Based on mitochondrial morphology and function
by: Yun Ma, et al.
Published: (2023-12-01)

Mechanism of Insomnia After Stroke Based on Intestinal Flora
by: Wang Y, et al.
Published: (2024-11-01)

Probiotics treatment ameliorated mycophenolic acid-induced colitis by enhancing intestinal barrier function and improving intestinal microbiota dysbiosis in mice
by: Pengpeng Zhang, et al.
Published: (2023-07-01)

Intestinal fatty acid binding protein is associated with cardiac function and gut dysbiosis in chronic heart failure
by: Andraž Nendl, et al.
Published: (2023-06-01)

The Rate of Histamine Degradation by Diamine Oxidase Is Compromised by Other Biogenic Amines
by: Sònia Sánchez-Pérez, et al.
Published: (2022-05-01)

Oral supplementation with lactic acid bacteria improve the intestinal epithelial barrier and gut microbiota of broiler chicks to alleviate Salmonella Enteritidis infection
by: Yuting Yang, et al.
Published: (2024-12-01)

Citrulline and intestinal fatty acid-binding protein as biomarkers for gastrointestinal dysfunction in the critically ill
by: Annika Blaser, et al.
Published: (2019-08-01)

Protective effects of chlorogenic acid on the intestinal barrier of broiler chickens: an immunological stress model study
by: Pingping Zha, et al.
Published: (2024-08-01)

Algal oil alleviates antibiotic-induced intestinal inflammation by regulating gut microbiota and repairing intestinal barrier
by: Huimin Zhang, et al.
Published: (2023-01-01)

Histamine Intolerance: The Current State of the Art
by: Oriol Comas-Basté, et al.
Published: (2020-08-01)

Is DAO in serum affected by food challenge with a histamine-rich meal?
by: Jenny van Odijk, RD, PhD, et al.
Published: (2023-05-01)

Intestinal Complication With Myxomatous Mitral Valve Diseases in Chihuahuas
by: R. Araki, et al.
Published: (2021-11-01)

Sesamin attenuates intestinal injury in sepsis via the HMGB1/TLR4/IL-33 signalling pathway
by: Zhi-Ling Li, et al.
Published: (2020-01-01)

The role of fatty acid-binding proteins in evaluating kidney involvement in patients with ankylosing spondylitis
by: L. V. Plenkina, et al.
Published: (2020-02-01)

Intestinal Oxygenotherapy of Critical Conditions
by: V. A. Mazurok, et al.
Published: (2017-12-01)

Histamine Intolerance—A Kind of Pseudoallergic Reaction
by: Ying Zhao, et al.
Published: (2022-03-01)

Evaluation of gama-aminobutyric acid (GABA) biosynthetic pathway in chickpea under cold stress
by: Saeed Amini, et al.
Published: (2020-10-01)

Endothelin Level and Its Correlation with Uric Acid in Type 2 Diabetic Multiuse Patients
by: Zahraa Majid Ismail, et al.
Published: (2020-08-01)

Bile Acids, Intestinal Barrier Dysfunction, and Related Diseases
by: Linsen Shi, et al.
Published: (2023-07-01)

Intestinal fatty acid bind protein as a biomarker for vitiligo
by: Olfat G. Shaker, et al.
Published: (2024-01-01)

L-FABP and I-FABP expression in newborn rats changes inversely in the model of necrotizing enterocolitis
by: Luís Felipe Tsuyoshi Mitidiero, et al.
Published: (2014-01-01)

Influence of Dialyzed Whey on the Growth and Nutrient Absorption from Small Intestine of Chickens
by: Ken R. Ito, et al.
Published: (2014-01-01)

Temporal profile of intestinal tissue expression of intestinal fatty acid-binding protein in a rat model of necrotizing enterocolitis
by: Ana Leda Bertoncini Simões, et al.